# Rongsheng Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rongsheng-medical

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Total disclosed funding: $1.5M
- Latest round: Angel (Apr 6, 2021)
- Investors on record: 1

## About

Established in 2019 and based in Suzhou, China, Rongsheng Medical is a medical device developer that focused on research and developing Lumen and blood vessel stent implantation products that can carry internal radioactive particles, with partners like Boston Scientific, Nanwei Medical, Southeast University, and the Supreme Ablation Research Institute. In April 2021, the company raised CNY10 million in angel funding from Qiaojing Capital. 

The company has developed a product that can carry iodine particle stents on malignant bile duct obstruction.

The company generates revenue through the sales of its medical products.

 In the future, the company plans to develop other cavities and vascular implant systems products.

## Funding rounds

- Angel, Apr 6, 2021, $1.5M — Qiaojing Capital

## Investors

- Qiaojing Capital (https://capitalatlas.ai/funds/qiaojing-capital) — Angel